Where to inject TRT: a practical guide to injection sites. - Reddit

The two routes: subcutaneous vs. intramuscular

Injectable testosterone is administered by two primary routes, and the decision between them affects needle choice, site options, absorption kinetics, and to some degree, how your protocol is structured.

Subcutaneous (SubQ) injection

Subcutaneous injection delivers testosterone into the layer of fat just beneath the skin, rather than into muscle. This approach uses shorter, thinner needles (typically 25–27 gauge, 5/8 inch), which most patients find less intimidating and less painful than intramuscular (IM) needles.

The absorption curve with SubQ is generally slower and flatter than with IM, meaning peak testosterone levels are lower but the drop-off is more gradual. For patients on twice-weekly or every-other-day protocols, this can produce steadier serum testosterone levels and reduce the peaks and troughs some patients experience with less frequent IM dosing.

Common subcutaneous sites include the lower abdomen (avoiding the area around the navel) and the outer thigh. These areas have accessible subcutaneous fat and are easy to reach for self-injection.

Intramuscular (IM) injection

Intramuscular injection delivers testosterone directly into muscle tissue, which allows for larger volumes and has historically been the most common method. Standard IM sites for TRT include:

• Ventrogluteal (VG): The preferred IM site for many clinicians. Located on the hip, it has a large muscle mass, fewer major blood vessels and nerves in the injection zone, and is reliably accessible. Finding the VG site correctly takes a brief orientation — your clinician or a how-to resource from your pharmacy can walk you through the landmark technique.
• Vastus lateralis (outer thigh): A commonly used self-injection site, particularly for patients who find the gluteal region difficult to access. The middle third of the outer thigh is the target zone. Avoid the inner thigh, which has more neurovascular structures.
• Deltoid (shoulder): Used for smaller volumes. The mid-deltoid — roughly the center of the upper arm — is the target. This site is appropriate when prescribed for small-volume protocols.
• Dorsogluteal (traditional “buttock” site): Historically common but increasingly disfavored by clinical guidelines due to proximity of the sciatic nerve. The ventrogluteal is now preferred for gluteal IM injections in most current guidance.

IM injections typically use a 22–25 gauge, 1–1.5-inch needle. The appropriate length depends on body composition — patients with more subcutaneous fat over the muscle may need longer needles to reliably reach muscle tissue.

Why does site rotation matter for TRT injections?

Rotating injection sites at every injection is not optional — it is a standard component of proper injection technique. Using the same site repeatedly causes:

• Lipohypertrophy: Overgrowth of fat tissue at the injection site from repeated trauma and the local effects of the oil carrier. This creates a lump that can impair absorption and become visibly noticeable.
• Scar tissue: Repeated injection in the same spot leads to fibrosis over time, hardening the tissue and making future injections more difficult.
• Inconsistent absorption: Scar tissue and lipohypertrophy can cause unpredictable testosterone release, affecting your serum levels and making dose management harder.

A simple rotation schedule alternates sides (left/right) and, if you use multiple site options, cycles through them systematically. For example, a twice-weekly injector might use the left thigh on Monday and the right thigh on Thursday, then shift to the ventrogluteal region the following week, and so on. Your clinician or pharmacy may provide a specific rotation map with your prescription materials.

Absorption and blood levels: what injection site choice means for your labs

The route of injection affects your testosterone pharmacokinetics — the shape of the absorption and elimination curve after each injection. This has practical significance for how your clinician interprets your labs and structures your protocol.

Research comparing SubQ and IM routes in men on testosterone therapy has generally found that SubQ produces lower peak levels and a more extended absorption period. For patients on weekly or twice-weekly dosing, SubQ can reduce the high-peak, low-trough pattern that some IM patients experience mid-cycle.

Whether peak-and-trough variation matters for a given patient depends on how they metabolize testosterone and whether they experience symptoms that correlate with the trough (low energy, mood changes near the next injection). If you notice symptoms that seem tied to the injection schedule, that is worth discussing with your clinician — it may inform whether adjusting injection frequency or switching routes is warranted.

How do you self-inject testosterone safely? Sterile technique step by step.

Injection-site infections are preventable. Standard sterile technique for self-injection of testosterone includes:

1. Wash hands thoroughly with soap and water before handling supplies.
2. Swab the injection site with an alcohol wipe and allow it to dry fully before injecting — wet alcohol at the injection site can sting and may carry surface bacteria into the puncture.
3. Use a new needle for every injection. Never reuse needles — they dull after one use, increasing tissue damage and infection risk.
4. Swab the vial stopper before drawing the dose if using a multi-dose vial.
5. Dispose of used needles in an approved sharps container, not the household trash.

Your pharmacy will provide needles, syringes, and alcohol swabs with your prescription. If you have questions about technique at any point, contact your prescribing clinician — this is what the check-in structure in a supervised protocol is for.

What to watch for and when to call your clinician

Minor discomfort after injection — a dull ache at the site for 24–48 hours — is common, particularly with oil-based testosterone formulations or when starting a new site. This typically resolves on its own.

Contact your clinician if you notice:

• Spreading redness, warmth, or swelling at the injection site that worsens after 24 hours.
• A persistent hard lump or nodule at an injection site that does not resolve.
• Fever or systemic symptoms following an injection.
• Significant pain that is disproportionate to what you normally experience.
• Signs of accidental IV injection: a metallic taste, coughing fit, or lightheadedness immediately after injection.

The last point is rare but worth knowing: if you accidentally inject into a vein (which can happen at certain sites without aspiration), the oil carrier can enter the bloodstream. It is generally self-limiting but warrants monitoring and reporting to your clinician.

Frequently asked questions